Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Cell cycle-dependent regulation of CDw75 (beta-galactoside alpha-2,6-sialyltransferase) on human B lymphocytes.

Erikstein BK, Funderud S, Beiske K, Aas-Eng A, De Lange Davies C, Blomhoff HK, Smeland EB.

Eur J Immunol. 1992 May;22(5):1149-55.

PMID:
1577059
3.

Human Golgi beta-galactoside alpha-2,6-sialyltransferase generates a group of sialylated B lymphocyte differentiation antigens.

Keppler OT, Moldenhauer G, Oppenländer M, Schwartz-Albiez R, Berger EG, Funderud S, Pawlita M.

Eur J Immunol. 1992 Nov;22(11):2777-81.

PMID:
1425905
4.
5.
6.
7.

The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.

Engel P, Nojima Y, Rothstein D, Zhou LJ, Wilson GL, Kehrl JH, Tedder TF.

J Immunol. 1993 Jun 1;150(11):4719-32.

PMID:
7684411
8.

n-butyrate reduces the expression of beta-galactoside alpha 2,6-sialyltransferase in Hep G2 cells.

Shah S, Lance P, Smith TJ, Berenson CS, Cohen SA, Horvath PJ, Lau JT, Baumann H.

J Biol Chem. 1992 May 25;267(15):10652-8.

9.

Differential expression of cell activation markers after stimulation of resting human B lymphocytes.

Kehrl JH, Muraguchi A, Fauci AS.

J Immunol. 1984 Jun;132(6):2857-61.

PMID:
6427329
10.

CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK/SAPK signaling cascade.

Tuscano JM, Riva A, Toscano SN, Tedder TF, Kehrl JH.

Blood. 1999 Aug 15;94(4):1382-92.

PMID:
10438726
11.

Human hematopoietic cell lines: a model system for study of minimal residual disease detection technique in acute leukemia.

Koníková E, Kusenda J, Babusíková O, Glasová M.

Neoplasma. 1995;42(5):227-34.

PMID:
8552200
12.

Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.

Lajaunias F, Ida A, Kikuchi S, Fossati-Jimack L, Martinez-Soria E, Moll T, Law CL, Izui S.

Arthritis Rheum. 2003 Jun;48(6):1612-21.

13.

Differential expression of the B cell-restricted molecule CD22 on neonatal B lymphocytes depending upon antigen stimulation.

Viemann D, Schlenke P, Hammers HJ, Kirchner H, Kruse A.

Eur J Immunol. 2000 Feb;30(2):550-9.

14.

CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin.

Sgroi D, Varki A, Braesch-Andersen S, Stamenkovic I.

J Biol Chem. 1993 Apr 5;268(10):7011-8.

15.

Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein.

Uckun FM, Haissig S, Ledbetter JA, Fidler P, Myers DE, Kuebelbeck V, Weisdorf D, Gajl-Peczalska K, Kersey JH, Ramsay NK.

Blood. 1992 Jun 15;79(12):3369-79.

PMID:
1375851
16.

Membrane CD22 defines circulating myeloma-related cells as mature or later B cells.

Perfetti V, Vignarelli MC, Bellotti V, Glennie MJ, Zorzoli I, Ubbiali P, Obici L, Massa M, Ippoliti G, Ascari E, Merlini G.

Lab Invest. 1997 Oct;77(4):333-44.

PMID:
9354768
17.

Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.

Ghetie MA, May RD, Till M, Uhr JW, Ghetie V, Knowles PP, Relf M, Brown A, Wallace PM, Janossy G, et al.

Cancer Res. 1988 May 1;48(9):2610-7. Erratum in: Cancer Res 1988 Aug 15;48(16):4716.

18.
19.

CDw75 antigen expression in breast lesions.

Reed W, Erikstein BK, Funderud S, Lilleng R, Tvedt K, Nesland JM.

Pathol Res Pract. 1993 May;189(4):394-8.

PMID:
7688897
20.

Supplemental Content

Support Center